Corbus Describes Phase 1 Results of ADC Trial for Bladder and Cervical Cancers
free of law Corbus Pharmaceuticals (NASDAQ:CRBP) said its antibody-drug conjugate, CRB-701, demonstrated promising efficacy and safety data in a Phase ...
Tag: Bladder
Merck's Keytruda Reduces Bladder Cancer Risk by 31% (NYSE:MRK)
News by Erik S. Lesser/Getty Images merck (New York Stock Exchange: MRK) announced detailed results from its Phase 3 AMBASSADOR ...
Recommended.
